Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Viive M. Howell
Identification of Novel Biomarkers in Pancreatic Tumor Tissue to Predict Response to Neoadjuvant Chemotherapy
Frontiers in Oncology
Cancer Research
Oncology
The Extracellular Matrix in Epithelial Ovarian Cancer – A Piece of a Puzzle
Frontiers in Oncology
Cancer Research
Oncology
Related publications
Molecular Biomarkers to Predict Response to Neoadjuvant Chemotherapy for Bladder Cancer
Cancer Treatment Reviews
Medicine
Oncology
Radiology
Nuclear Medicine
Imaging
Multiagent Neoadjuvant Chemotherapy and Tumor Response Are Associated With Improved Survival in Pancreatic Cancer
HPB
Hepatology
Gastroenterology
Identification of Biomarkers Including 18fdg-Pet/Ct for Early Prediction of Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer
Clinical Cancer Research
Cancer Research
Oncology
Pathologic Tumor Response to Neoadjuvant Chemotherapy in Gastroesophageal Cancer: What Does It Mean?
Translational Gastroenterology and Hepatology
Deletions of Multidrug Resistance Gene Loci in Breast Cancer Leads to the Down-Regulation of Its Expression and Predict Tumor Response to Neoadjuvant Chemotherapy
Oncotarget
Oncology
Integration of Pathologic Findings With Clinical-Radiologic Tumor Measurements to Quantify Response to Neoadjuvant Chemotherapy
Monitoring the Responsiveness of T and Antigen Presenting Cell Compartments in Breast Cancer Patients Is Useful to Predict Clinical Tumor Response to Neoadjuvant Chemotherapy
BMC Cancer
Cancer Research
Oncology
Genetics
Sustained CA19-9 Response to Neoadjuvant Chemotherapy in Borderline Resectable Pancreatic Cancer Predicts Progression and Survival
Oncologist
Cancer Research
Medicine
Oncology
Indoleamine-2,3-Dioxygenase and Interleukin-6 Associated With Tumor Response to Neoadjuvant Chemotherapy in Breast Cancer
Oncotarget
Oncology
